At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 100 enrolled
Drug / intervention
Propofol slow administrationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Analyzing the Relationship Between Rate of Induction and Perioperative Hypotension Using Propofol
In Brief
A Phase 3 clinical trial evaluating Propofol slow administration for Hypotension on Induction. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the hemodynamic changes related to Propofol administration rate. We hypothesize that slow administration of IV propofol will have less hemodynamic disturbances and will require less amount of vasoactive medication for BP correction when compared to standard FDA approved administration rate.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypotension on Induction
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2023202420252026
First PostedJun 2022
Enrollment StartAug 2022
Primary CompletionJun 2023
Study CompletionJul 2023
TodayJul 2026
First PostedJun 13, 2022
Enrollment StartAug 11, 2022
Primary CompletionJun 30, 2023
Study CompletionJul 21, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.1 years ago
Interventions
Propofol slow administrationother
Propofol will be slowly administered over 120 seconds by anesthesia provider